美国 · SEC FORM 4
VERACYTE, INC.
VCYT · Nasdaq · CIK 0001384101 · Healthcare · Diagnostics & Research
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
43 同一窗口内观察到的 Form 4 交易行
21 sales · 22 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-06-10 · Stapley Marc.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 10,178,975
- 上期报告
- 8,403,932
- 日均成交量
- 1,729,842
- 回补天数
- 5.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
118 transaction lines in the latest 365-day window; 667 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-21 | Leite John | 卖出 (S) | Common Stock | 4,015 | USD 40.00 | USD 160,600 | SEC 申报 ↗ |
| 2026-09-14 | Holstein Jens | 卖出 (S) | Common Stock | 5,000 | USD 40.95 | USD 204,750 | SEC 申报 ↗ |
| 2026-09-04 | McGuire Annie | 卖出 (S) | Common Stock | 3,254 | USD 43.09 | USD 140,207 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-21 | Leite John | 卖出 (S) | Common Stock | 4,015 | USD 40.00 | USD 160,600 | SEC 申报 ↗ |
| 2026-09-14 | Holstein Jens | 卖出 (S) | Common Stock | 5,000 | USD 40.95 | USD 204,750 | SEC 申报 ↗ |
| 2026-09-04 | McGuire Annie | 卖出 (S) | Common Stock | 3,254 | USD 43.09 | USD 140,207 | SEC 申报 ↗ |
| 2026-09-04 | Febbo Phillip G. | 卖出 (S) | Common Stock | 13,110 | USD 43.05 | USD 564,371 | SEC 申报 ↗ |
| 2026-09-04 | Chambers Rebecca | 卖出 (S) | Common Stock | 3,652 | USD 43.10 | USD 157,400 | SEC 申报 ↗ |
| 2026-09-02 | Wygant Jonathan | 代扣税 (F) | Common Stock | 1,361 | USD 44.88 | USD 61,082 | SEC 申报 ↗ |
| 2026-09-02 | Stapley Marc | 代扣税 (F) | Common Stock | 8,782 | USD 44.88 | USD 394,136 | SEC 申报 ↗ |
| 2026-09-02 | McGuire Annie | 代扣税 (F) | Common Stock | 3,215 | USD 44.88 | USD 144,289 | SEC 申报 ↗ |
| 2026-09-02 | Leite John | 代扣税 (F) | Common Stock | 3,961 | USD 44.88 | USD 177,770 | SEC 申报 ↗ |
| 2026-09-02 | Febbo Phillip G. | 代扣税 (F) | Common Stock | 3,639 | USD 44.88 | USD 163,318 | SEC 申报 ↗ |
| 2026-09-02 | Chambers Rebecca | 代扣税 (F) | Common Stock | 3,603 | USD 44.88 | USD 161,703 | SEC 申报 ↗ |
| 2026-09-01 | Bhanji Muna | 卖出 (S) | Common Stock | 1,864 | USD 42.97 | USD 80,096 | SEC 申报 ↗ |
| 2026-06-18 | EASTHAM KARIN | 卖出 (S) | Common Stock | 3,729 | USD 52.89 | USD 197,224 | SEC 申报 ↗ |
| 2026-06-11 | Shafer David Brent | 奖励／授予 (A) | Common Stock | 5,272 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Miller Thomas F. | 奖励／授予 (A) | Common Stock | 5,272 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | JONES EVAN/ FA | 奖励／授予 (A) | Common Stock | 5,272 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Holstein Jens | 奖励／授予 (A) | Common Stock | 5,272 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | EPSTEIN ROBERT S | 奖励／授予 (A) | Common Stock | 5,272 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | EASTHAM KARIN | 奖励／授予 (A) | Common Stock | 5,272 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Bhanji Muna | 奖励／授予 (A) | Common Stock | 5,272 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-11 | Barr Eliav | 奖励／授予 (A) | Common Stock | 5,272 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-04 | Stapley Marc | 卖出 (S) | Common Stock | 138,051 | USD 50.12 | USD 6,919,116 | SEC 申报 ↗ |
| 2026-06-04 | Stapley Marc | 期权行权／转换 (M) | Common Stock | 138,051 | USD 36.60 | USD 5,052,667 | SEC 申报 ↗ |
| 2026-06-04 | McGuire Annie | 卖出 (S) | Common Stock | 3,176 | USD 49.76 | USD 158,047 | SEC 申报 ↗ |
| 2026-06-04 | Leite John | 卖出 (S) | Common Stock | 13,975 | USD 50.07 | USD 699,728 | SEC 申报 ↗ |
| 2026-06-04 | Chambers Rebecca | 卖出 (S) | Common Stock | 3,561 | USD 49.73 | USD 177,074 | SEC 申报 ↗ |
| 2026-06-02 | Wygant Jonathan | 代扣税 (F) | Common Stock | 1,361 | USD 47.80 | USD 65,056 | SEC 申报 ↗ |
| 2026-06-02 | Stapley Marc | 代扣税 (F) | Common Stock | 9,012 | USD 47.80 | USD 430,774 | SEC 申报 ↗ |
| 2026-06-02 | McGuire Annie | 代扣税 (F) | Common Stock | 3,292 | USD 47.80 | USD 157,358 | SEC 申报 ↗ |
| 2026-06-02 | Leite John | 代扣税 (F) | Common Stock | 4,059 | USD 47.80 | USD 194,020 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | VCYT |
| CIK | 0001384101 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 667 transaction lines from 2020-01-10 to 2026-09-21 2 P purchase lines · 269 S sale lines · 396 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.